Halozyme Therapeutics
↗San Diego, USA
Halozyme Therapeutics is a leading biopharmaceutical technology platform company that specializes in innovative drug delivery solutions. The company is best known for its proprietary ENHANZE® drug delivery technology, which utilizes a recombinant human hyaluronidase enzyme (rHuPH20) to enable the subcutaneous administration of injectable biologics that are traditionally delivered intravenously. This technology significantly reduces treatment time and improves the patient experience by allowing for rapid, high-volume injections.
Beyond its core ENHANZE® platform, Halozyme has expanded its portfolio through strategic acquisitions, including Antares Pharma (auto-injector technology), Elektrofi (Hypercon™ ultra-high concentration technology), and Surf Bio (polymer-based hyperconcentration). The company operates a high-margin business model centered on licensing its technology to global pharmaceutical leaders and collecting royalties on blockbuster products such as DARZALEX SC and Phesgo. Halozyme also maintains a proprietary portfolio of commercial products, including XYOSTED® and Hylenex®.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$1B-$2B
Founded:1998
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$245M
Investors:BlackRock, The Vanguard Group, State Street Global Advisors, Colt Ventures
STOCK
Exchange:NASDAQ
Ticker:HALO
Market Cap:$9.3B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Enzyme, mAb, ADC, Small molecule, Drug-device combinations
Active Trials:15
Trial Phases:Phase 1: 4 | Phase 2: 5 | Phase 3: 6
FDA Approvals:10
EMA Approvals:8
CORPORATE STRUCTURE
Subsidiaries:Antares Pharma, Elektrofi, Surf Bio
Key Partnerships:Roche, Johnson & Johnson (Janssen), Bristol Myers Squibb, Pfizer, argenx, Takeda, AbbVie, Eli Lilly, ViiV Healthcare, Skye Bioscience
COMPETITION
Position:Leader
Competitors:Alteogen, Heron Therapeutics, MedPharm, Catalent, West Pharmaceutical Services
LEADERSHIP
Key Executives:
Helen Torley - President & CEO
Nicole LaBrosse - SVP & CFO
Steve Knowles - Chief Medical Officer
Scientific Founders:Gregory Frost, Jonathan Lim
Board Members:Connie Matsui (Chair), Jeffrey Henderson, Bernadette Connaughton, James Daly, Jean-Pierre Bizzari
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Halozyme Therapeutics. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.